TBThomas Barnay

Thomas Barnay

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Thomas Barnay has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Did the 2005 French Disabled workers Act increase the employment rate of people with disabilities? An econometric evaluation on panel data

    by Thomas Barnay, Emmanuel Duguet, Yann Videau

    This paper delivers the first evaluation of the 2005 French Disability Act, which was introduced to promote the employment of disabled people. The Act relies primarily on a legal employment quota for disabled people, with levies imposed in cases of non-compliance. We apply panel data methods equivalent to double and triple difference methods to the French Santé et Itinéraire Professionnel (SIP) survey (Survey on Health and Labour Market Histories). First, we estimate the effect of disability on the employment rate, finding a strong negative effect which is most pronounced among men and the oldest workers. However, since some observable characteristics of disabled workers, such as age, gender and education, vary over time, we extend our model to isolate the causal effect of the reform on the employment rate of disabled workers by taking into account the pre-reform (1991–2004) and post-reform (2005–2009) periods. Our findings suggest that the 2005 Act has met its initial objective, positively impacting the employment rate of disabled individuals, particularly in the private sector. The reform appears to have compensated for approximately half of the effect of disabilities on the employment rate. We also find that the reform's effect has been stronger for workers with secondary education.

  • Open Access

    Work strains and disabilities in French workers: A career‐long retrospective study

    by Thomas Barnay, Éric Defebvre


  • Open Access

    A Two-Step Frailty Assessment Strategy in Older Patients With Solid Tumors: A Decision Curve Analysis

    by Adolfo González Serrano, Marie Laurent, Thomas Barnay, Claudia Martínez-Tapia, Etienne Audureau, Pascaline Boudou-Rouquette, Thomas Aparicio, Florence Rollot-Trad, Pierre Soubeyran, Carine Bellera, et al.

    PURPOSE: The intended clinical value of frailty screening is to identify unfit patients needing geriatric assessment (GA) and to prevent unnecessary GA in fit patients. These hypotheses rely on the sensitivity and specificity of screening tests, but they have not been verified. METHODS: We performed a cross-sectional analysis of outpatients age ≥ 70 years with prostate, breast, colorectal, or lung cancer included in the ELCAPA cohort study (ClinicalTrials.gov identifier: NCT02884375 ) between February 2007 and December 2019. The diagnostic accuracy of the G8 Geriatric Screening Tool (G8) and modified G8 scores for identifying unfit patients was determined on the basis of GA results. We used decision curve analysis to calculate the benefit of frailty screening for detecting unfit patients and avoiding unnecessary GA in fit patients across different threshold probabilities. RESULTS: We included 1,648 patients (median age, 81 years), and 1,428 (87%) were unfit. The sensitivity and specificity were, respectively, 85% (95% CI, 84 to 87) and 59% (95% CI, 57 to 61) for G8, and 86% (95% CI, 84 to 87) and 60% (95% CI, 58 to 63) for the modified G8 score. For decision curve analysis, the net benefit (NB) for identifying unfit patients were 0.72 for G8, 0.72 for the modified G8, and 0.82 for GA at a threshold probability of 0.25. At a threshold probability of 0.33, the NBs were 0.71, 0.72, and 0.80, respectively. At a threshold probability of 0.5, the NBs were 0.68, 0.69, and 0.73, respectively. No screening tool reduced unnecessary GA in fit patients at predefined threshold probabilities. CONCLUSION: Although frailty screening tests showed good diagnostic accuracy, screening showed no clinical benefits over the GA-for-all strategy. NB approaches, in addition to diagnostic accuracy, are necessary to assess the clinical value of tests.


  • Open Access

    Adherence to Treatment Guidelines and Associated Survival in Older Patients with Prostate Cancer: A Prospective Multicentre Cohort Study

    by Adolfo González Serrano, Claudia Martínez Tapia, Alexandre de la Taille, Pierre Mongiat-Artus, Jacques Irani, Axel Bex, Elena Paillaud, Etienne Audureau, Thomas Barnay, Marie Laurent, et al.

    The guidelines on prostate cancer treatment in older men recommend evaluating the patient’s underlying health status before treatment selection. We aimed to evaluate the frequency of a guideline–discordant treatment (GDT), identify factors associated with GDT, and assess the relationship between GDT and overall survival. We studied patients with prostate cancer aged 70 or older included in the ELCAPA cohort between 2010 and 2019. Multivariable logistic regression assessed GDT-associated factors. The restricted mean survival time (RMST) assessed the 24- and 36-month OS using stabilized inverse probability of treatment weighting of propensity scores. We included 356 patients (median age: 81 years), and 164 (46%) received a GDT (95% confidence interval (CI) = (41–51%)). Patients with metastases were less likely to receive a GDT (adjusted odds ratio (95% CI) = 0.34 (0.17–0.69); p = 0.003). After weighting, the RMST at 24 months was shorter in the GDT group (13.9 months, vs. 17 months for compliant treatments; difference (95% CI): −3.1 months (−5.3, −1.0); p = 0.004). RMST at 36 months was 18.5 months, vs. 21.8 months (difference: −3.3 months (−6.7, 0.0); p = 0.053). GDT is common in older patients with prostate cancer and especially those with non-metastatic disease. GDT was associated with worse survival, independently of health status and tumour characteristics.


  • Real-life implementation and survival outcomes of geriatric-assessement-based guidelines for treatment decision in older patients with prostate cancer: The ELCAPA-26 cohort study

    by A. González Serrano, C. Martinez Tapia, A. De La Taille, P. Mongiat-Artus, J. Irani, A. Bex, E. Paillaud, E. Audureau, T. Barnay, M. Laurent, et al.

  • Open Access

    Impact of type 2 diabetes on health expenditure: estimation based on individual administrative data

    by François-Olivier Baudot, Anne-Sophie Aguadé, Thomas Barnay, Christelle Gastaldi-Ménager, Anne Fagot-Campagna

    Only limited data are available in France on the incidence and health expenditure of type 2 diabetes. The objective of this study, based on national health insurance administrative database, is to describe the expenditure reimbursed to patients newly treated for type 2 diabetes and the proportion of expenditure attributable to diabetes. The study is conducted over a 6-year period from 2008, the year of incidence of treated diabetes, to 2014. Type 2 diabetic patients aged 45 years and older are identified on the basis of their drug consumption. To estimate expenditure attributable to diabetes, a matched control group is selected among more than 13 million beneficiaries over 44 years old not taking antidiabetic treatment. The expenditure attributable to diabetes is estimated by two methods: simple comparison of reimbursed health expenditure between both groups, and a difference-in-differences method including control variables. The cohort of incident type 2 diabetic patients comprises 170,013 patients in 2008. Mean global reimbursed expenditure is €4700 per patient in 2008 and €5500 in 2015. Expenditure attributable to diabetes, estimated by direct comparison with controls, is €1500 in the first year. We, thus, observe a decrease in the following year due to decreased hospitalisations, and then expenditure increase by an average of 7% per year to reach €1900 in the eighth year after the initiation of treatment.


  • An evaluation of the 1987 French Disabled Workers Act: better paying than hiring

    by Thomas Barnay, Emmanuel Duguet, Christine Le Clainche, Yann Videau

    This paper presents the first evaluation of the French Disabled Workers Act of 1987, which aimed to promote the employment of disabled people in the private sector. We use a panel data set, which includes both the health and the labour market histories of workers. We account both for unobserved heterogeneity and for the change in the disabled population over time. We find that the law had a negative impact on the employment of disabled workers in the private sector. This counterproductive effect likely comes from the possibility to pay a fine instead of hiring disabled workers.


  • Open Access

    L’influence des conditions de travail passées sur la santé et la consommation de médicaments auto-déclarées des retraités

    by Thomas Barnay, Éric Defebvre

    Cet article vise à mesurer l’effet propre des conditions de travail physiques et psychosociales rencontrées durant l’ensemble de la carrière professionnelle sur la santé physique et mentale auto-déclarée et la consommation de médicaments des retraités. Pour ce faire, nous mobilisons les données de l’enquête Santé et itinéraire professionnel (Sip). Nous contrôlons nos résultats des caractéristiques socio-économiques, d’itinéraire professionnel et de caractéristiques individuelles antérieures à l’entrée sur le marché du travail mais également de l’état de santé dans l’enfance et à l’âge adulte. Nos résultats mettent en évidence le rôle négatif des conditions de travail passées sur la santé physique et mentale des retraités avec un lien clair entre contraintes physiques et santé physique d’une part et risques psychosociaux et santé mentale (incluant la consommation de médicaments) d’autre part. Ce résultat témoigne du caractère pénalisant de long terme des conditions de travail pénibles sur la santé des retraités.